Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
Clinical trial NCT03126916 · RECRUITING
Trial details
- NCT number
- NCT03126916
- Sponsor
- Children's Oncology Group
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-14
- Primary completion
- 2030-09-30
- Enrollment
- 750
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.